QUANTA DIALYSIS TECHNOLOGIES LIMITED

• ⚠

  Material uncertainty over going concern

  Accordingly, the directors have prepared the financial statements on a going concern basis. However, the forecast level of revenue and expenditure is uncertain and there is also no certainty that any further fundraising (if secured) will be sufficient to cover future cash flow requirements. These conditions indicate a material uncertainty that may cast significant doubt about the Group's and Company's ability to continue as a going concern and, therefore, to continue realizing its assets and discharging its liabilities in the normal course of business.

1. QUANTA DIALYSIS TECHNOLOGIES LIMITED 2016-07-01 → present
2. QUANTA FLUID SOLUTIONS LTD 2008-08-04 → 2016-07-01
3. PIMCO 2800 LIMITED 2008-07-08 → 2008-08-04

Accounting basis

IFRS

Reporting scope

Consolidated group

Auditor

PricewaterhouseCoopers LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“Accordingly, the directors have prepared the financial statements on a going concern basis. However, the forecast level of revenue and expenditure is uncertain and there is also no certainty that any further fundraising (if secured) will be sufficient to cover future cash flow requirements. These conditions indicate a material uncertainty that may cast significant doubt about the Group's and Company's ability to continue as a going concern and, therefore, to continue realizing its assets and discharging its liabilities in the normal course of business.”

Group structure

1. QUANTA DIALYSIS TECHNOLOGIES LIMITED · parent
   1. Quanta Fluid Solutions Limited 100% · England · Dormant
   2. Quanta Dialysis Technologies Incorporated 100% · USA · Sell and distribute dialysis products and services

Significant events

• “In November 2024, Quanta achieved a significant milestone by receiving U.S. Food and Drug Administration (FDA) 510(k) clearance for the use of its Quanta Dialysis System in the home setting.”
• “In December 2023, Quanta made a strategic decision to exit the UK commercial market to concentrate focus on the US market. Quanta completed its commercial exit from the UK in the first half of 2024.”
• “In November 2024, the Company successfully completed the issuance of Series E Preferred Stock, generating gross proceeds of £46.8 million to support continued commercial expansion and strategic initiatives.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

5

last 12 months

Capital events

4

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.